835 Heterologous prime boost viral vector vaccination provides protection against intracranial syngeneic murine glioblastoma

• Mark Gilbert,
• Wei Zhang,
• Hideho Okada,
• Masaki Terabe,
• Gary Kohanbash,
• Hua Song,
• Dionne Davis,
• James McAuliffe,
• Laurine Noblecourt,
• Emily E Steffke,
• Taijun Hana,
• Laila Latifi,
• Vinnycius Pereira Almeida,
• Amanda Wicki,
• Morgan Coombs,
• Nargis Malik,
• Meili Zhang,
• Nicole Briceno,
• Carol Leung,
• Benoit Van den Eynde

Affiliations

Mark Gilbert

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Wei Zhang

Biomedical Informatics & Statistics Center, School of Public Health, Fudan University, Shanghai, China

Hideho Okada

4University of California, San Francisco, San Francisco, CA, USA

Masaki Terabe

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Gary Kohanbash

3University of Pittsburgh, Pittsburgh, PA, USA

Hua Song

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Dionne Davis

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

James McAuliffe

2University of Oxford, Oxford, UK

Laurine Noblecourt

2University of Oxford, Oxford, UK

Emily E Steffke

2University of Oxford, Oxford, UK

Taijun Hana

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Laila Latifi

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Vinnycius Pereira Almeida

2University of Oxford, Oxford, UK

Amanda Wicki

2University of Oxford, Oxford, UK

Morgan Coombs

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Nargis Malik

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Meili Zhang

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Nicole Briceno

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Carol Leung

2University of Oxford, Oxford, UK

Benoit Van den Eynde

2University of Oxford, Oxford, UK